Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 9.770 | 9.770 | 0.000 |
| Shares | 91.730 | 91.730 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 27.890 | 34.228 |
| Price to Book | 2.749 | 4.369 |
| Price to Sales | 4.743 | 6.566 |
| Price to Cash Flow | 20.328 | 24.994 |
| Dividend Yield | 1.402 | 1.451 |
| 5 Years Earnings Growth | 5.079 | 6.323 |
| Name | Net % | Category Average |
|---|---|---|
| Healthcare | 95.730 | 94.079 |
| Consumer Defensive | 2.650 | 4.796 |
| Consumer Cyclical | 1.620 | 1.032 |
Number of long holdings: 30
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Ningbo Menovo Pharma | CNE100002Y25 | 7.03 | 22.11 | +1.94% | |
| Beijing Balance Medical Technology Co | CNE100005X15 | 6.08 | 123.98 | +2.46% | |
| Jiangsu Hengrui | CNE0000014W7 | 5.69 | 62.90 | -1.04% | |
| SWS Hemodialysis Care | CNE100005VK9 | 5.55 | 16.95 | +3.48% | |
| Shenzhen Mindray Bio-Medical | CNE100003G67 | 5.26 | 207.70 | -0.24% | |
| Mehow Innovative | CNE100005WP6 | 4.80 | 21.80 | -1.89% | |
| TREASURY COUPON BOND 2024 15 | - | 4.74 | - | - | |
| Beijing Kawin Technology Shareholding Co | CNE1000054C3 | 4.70 | 28.61 | -0.69% | |
| Jiuzhitang A | CNE000001394 | 4.58 | 10.58 | +2.32% | |
| Aurisco Pharmaceutical Co | CNE1000042S4 | 4.58 | 23.52 | +0.77% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Fuanda Advantage Growth Stock | 857.29M | 66.34 | 14.84 | 9.15 | ||
| FuAnDa Emerging Gr Alloc Fd | 71.24M | 39.19 | -8.30 | -3.76 | ||
| FuAnDa Strategy Select Balance Fund | 33.75M | 3.38 | -8.62 | 1.46 | ||
| FuAnDa Emerging Power Alloc Fd | 10.58M | 21.41 | -9.70 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review